JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB51252

Anti-alpha + beta Synuclein antibody [EP1646Y]

4

(1 Review)

|

(28 Publications)

Rabbit Recombinant Monoclonal Alpha-synuclein antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Mouse, Human, Rat samples. Cited in 28 publications.

View Alternative Names

NACP, PARK1, SNCA, Alpha-synuclein, Non-A beta component of AD amyloid, Non-A4 component of amyloid precursor, Beta-synuclein, SNCB

7 Images
Flow Cytometry (Intracellular) - Anti-alpha + beta Synuclein antibody [EP1646Y] (AB51252)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-alpha + beta Synuclein antibody [EP1646Y] (AB51252)

Overlay histogram showing U87-MG cells fixed in 4% PFA and stained with purified ab51252 at a dilution of 1 in 30 (red line). The secondary antibody used was FITC goat anti-rabbit at a dilution of 1 in 500. Rabbit monoclonal IgG was used as an isotype control (black line) and cells incubated in the absence of both primary and secondary antibody were used as a negative control (blue line).

Flow Cytometry (Intracellular) - Anti-alpha + beta Synuclein antibody [EP1646Y] (AB51252)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-alpha + beta Synuclein antibody [EP1646Y] (AB51252)

Overlay histogram showing SH-SY5Y cells stained with unpurifiedab51252 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (unpurified ab51252, 1/1000 dilution) for 30 min at 22°C. The secondary antibody used was Alexa Fluorr® 488 goat anti-rabbit IgG (H+L) (ab150077) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (0.1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter.

Immunocytochemistry/ Immunofluorescence - Anti-alpha + beta Synuclein antibody [EP1646Y] (AB51252)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-alpha + beta Synuclein antibody [EP1646Y] (AB51252)

Immunocytochemistry/Immunofluorescence analysis of PC-12 cells labelling alpha + beta Synuclein with purified ab51252 at 1/100. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. DAPI (blue) was used as the nuclear counterstain. ab7291, a mouse anti-tubulin (1/1000) and ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/1000) were also used.

Control 1 : primary antibody (1/100) and secondary antibody, ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/1000).

Control 2 : ab7291 (1/1000) and secondary antibody, ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000).

Western blot - Anti-alpha + beta Synuclein antibody [EP1646Y] (AB51252)
  • WB

Lab

Western blot - Anti-alpha + beta Synuclein antibody [EP1646Y] (AB51252)

Blocking and dilution buffer : 5% NFDM /TBST.

All lanes:

Western blot - Anti-alpha + beta Synuclein antibody [EP1646Y] (ab51252) at 1/5000 dilution

All lanes:

Human cerebellum tissue lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 14 kDa

Observed band size: 18 kDa

false

Western blot - Anti-alpha + beta Synuclein antibody [EP1646Y] (AB51252)
  • WB

Lab

Western blot - Anti-alpha + beta Synuclein antibody [EP1646Y] (AB51252)

Blocking and dilution buffer : 5% NFDM /TBST.

All lanes:

Western blot - Anti-alpha + beta Synuclein antibody [EP1646Y] (ab51252) at 1/5000 dilution

Lane 1:

Mouse brain tissue lysate at 20 µg

Lane 2:

Rat brain tissue lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 14 kDa

Observed band size: 18 kDa

false

Western blot - Anti-alpha + beta Synuclein antibody [EP1646Y] (AB51252)
  • WB

Unknown

Western blot - Anti-alpha + beta Synuclein antibody [EP1646Y] (AB51252)

All lanes:

Western blot - Anti-alpha + beta Synuclein antibody [EP1646Y] (ab51252) at 1/50000 dilution

All lanes:

Human fetal brain tissue lysate at 10 µg

Secondary

All lanes:

HRP-conjugated goat anti-rabbit IgG at 1/2000 dilution

Predicted band size: 14 kDa

Observed band size: 18 kDa

false

Western blot - Anti-alpha + beta Synuclein antibody [EP1646Y] (AB51252)
  • WB

Supplier Data

Western blot - Anti-alpha + beta Synuclein antibody [EP1646Y] (AB51252)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

This antibody does not cross-react with human beta Synuclein and alpha Synuclein.

In Western blot, Anti-6X His tag® antibody [EPR20547] - ChIP Grade (ab213204) staining at 1/5000 dilution.

In Western blot, Anti-alpha + beta Synuclein antibody [EP1646Y] - (ab51252) staining at 1/1000 dilution.

All lanes:

Western blot - Anti-gamma Synuclein/SNCG antibody [EPR26218-79] (<a href='/en-us/products/primary-antibodies/gamma-synuclein-sncg-antibody-epr26218-79-ab315442'>ab315442</a>) at 1/1000 dilution

Lane 1:

His-tagged human gamma Synuclein recombinant protein at 10 ng

Lane 2:

His-tagged human beta Synuclein recombinant protein at 10 ng

Lane 3:

His-tagged human alpha Synuclein recombinant protein at 10 ng

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Observed band size: 14 kDa,20 kDa,19 kDa

false

Exposure time: 59s

  • Carrier free

    Anti-alpha + beta Synuclein antibody [EP1646Y] - BSA and Azide free

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-alpha + beta Synuclein antibody [EP1646Y]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP1646Y

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

ICC/IF, WB, Flow Cyt (Intra)

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000", "WB-species-notes": "<p><strong>For unpurified use at 1/50000.</strong></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/30", "FlowCytIntra-species-notes": "<p>For unpurified use at 1/1000.<a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" }, "Mouse": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000", "WB-species-notes": "<p><strong>For unpurified use at 1/50000.</strong></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Rat": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/50 - 1/100", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Conditional Ambient
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Alpha-synuclein and beta-synuclein are proteins implicated in the dynamics of neuronal function. Alpha-synuclein also known as SNCA is a synaptic protein weighing approximately 14 kDa expressed highly in the central nervous system. Unlike alpha-synuclein beta-synuclein shares a similar structure but differs in function and molecular weight. Both proteins belong to the synuclein family which also includes gamma-synuclein and are found primarily in pre-synaptic terminals contributing to synaptic vesicle physiology.
Biological function summary

Alpha- and beta-synuclein play roles in synaptic function and plasticity where they influence neurotransmitter release and vesicle recycling. These proteins do not generally form a stable complex with each other but their presence together suggests a regulatory interplay. Alpha-synuclein may promote vesicle formation and trafficking while beta-synuclein appears to counteract alpha's effects potentially protecting neurons from alpha-synuclein aggregation.

Pathways

Alpha- and beta-synuclein are key components in the synaptic vesicle cycle especially associated with the SNARE complex and neurotransmitter balance. Alpha-synuclein interacts with proteins like VAMP2 and STX1A in vesicle merging while beta-synuclein's regulatory role has implications in maintaining these interactions. In lipid metabolism alpha-synuclein influences fatty acid binding protein pathways impacting neuronal lipid transport and homeostasis.

Alpha- and beta-synuclein hold significant relevance particularly in neurodegenerative disorders like Parkinson's disease and dementia with Lewy bodies which show marked alpha-synuclein aggregates known as Lewy bodies. Alpha-synuclein's accumulation in neurons correlates with disease progression. Beta-synuclein on the other hand appears to have a protective role potentially mitigating the toxicity of alpha's aggregates. The relation between these synucleins underlines their importance in therapeutic research for these disorders.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Neuronal protein that plays several roles in synaptic activity such as regulation of synaptic vesicle trafficking and subsequent neurotransmitter release (PubMed : 20798282, PubMed : 26442590, PubMed : 28288128, PubMed : 30404828). Participates as a monomer in synaptic vesicle exocytosis by enhancing vesicle priming, fusion and dilation of exocytotic fusion pores (PubMed : 28288128, PubMed : 30404828). Mechanistically, acts by increasing local Ca(2+) release from microdomains which is essential for the enhancement of ATP-induced exocytosis (PubMed : 30404828). Also acts as a molecular chaperone in its multimeric membrane-bound state, assisting in the folding of synaptic fusion components called SNAREs (Soluble NSF Attachment Protein REceptors) at presynaptic plasma membrane in conjunction with cysteine string protein-alpha/DNAJC5 (PubMed : 20798282). This chaperone activity is important to sustain normal SNARE-complex assembly during aging (PubMed : 20798282). Also plays a role in the regulation of the dopamine neurotransmission by associating with the dopamine transporter (DAT1) and thereby modulating its activity (PubMed : 26442590).
See full target information SNCA

Additional targets

SNCB

Publications (28)

Recent publications for all applications. Explore the full list and refine your search

Acta neuropathologica communications 11:201 PubMed38110990

2023

Cellular and subcellular localization of Rab10 and phospho-T73 Rab10 in the mouse and human brain.

Applications

Unspecified application

Species

Unspecified reactive species

Vijay Singh,Marissa A Menard,Geidy E Serrano,Thomas G Beach,Hien T Zhao,Alexis Riley-DiPaolo,Nitya Subrahmanian,Matthew J LaVoie,Laura A Volpicelli-Daley

Nature communications 14:3126 PubMed37253751

2023

Allosteric regulation of the 20S proteasome by the Catalytic Core Regulators (CCRs) family.

Applications

Unspecified application

Species

Unspecified reactive species

Fanindra Kumar Deshmukh,Gili Ben-Nissan,Maya A Olshina,Maria G Füzesi-Levi,Caley Polkinghorn,Galina Arkind,Yegor Leushkin,Irit Fainer,Sarel J Fleishman,Dan Tawfik,Michal Sharon

The Journal of neuroscience : the official journal of the Society for Neuroscience 43:501-521 PubMed36639889

2023

Neuronopathic GBA1L444P Mutation Accelerates Glucosylsphingosine Levels and Formation of Hippocampal Alpha-Synuclein Inclusions.

Applications

Unspecified application

Species

Unspecified reactive species

Casey L Mahoney-Crane,Megha Viswanathan,Dreson Russell,Rachel A C Curtiss,Jennifer Freire,Sai Sumedha Bobba,Sean D Coyle,Monika Kandebo,Lihang Yao,Bang-Lin Wan,Nathan G Hatcher,Sean M Smith,Jacob N Marcus,Laura A Volpicelli-Daley

iScience 25:103908 PubMed35243260

2022

induces mitochondrial calcium overload and α -synuclein aggregation in an enteroendocrine cell line.

Applications

Unspecified application

Species

Unspecified reactive species

Dionísio Pedro Amorim Neto,Beatriz Pelegrini Bosque,João Vitor Pereira de Godoy,Paulla Vieira Rodrigues,Dario Donoso Meneses,Katiane Tostes,Celisa Caldana Costa Tonoli,Hernandes Faustino de Carvalho,Christian González-Billault,Matheus de Castro Fonseca

Frontiers in cell and developmental biology 9:741662 PubMed34552934

2021

Interactions and Cytotoxicity of Human Neurodegeneration- Associated Proteins Tau and α-Synuclein in the Simple Model .

Applications

Unspecified application

Species

Unspecified reactive species

Katelyn Mroczek,Sanjanie Fernando,Paul R Fisher,Sarah J Annesley

Molecular psychiatry 26:6083-6099 PubMed34234281

2021

PIAS2-mediated blockade of IFN-β signaling: a basis for sporadic Parkinson disease dementia.

Applications

Unspecified application

Species

Unspecified reactive species

Joana Magalhaes,Emilie Tresse,Patrick Ejlerskov,Erling Hu,Yawei Liu,Andrea Marin,Alexia Montalant,Letizia Satriano,Carsten Friis Rundsten,Eva Maria Meier Carlsen,Rasmus Rydbirk,Ali Sharifi-Zarchi,Jesper Bøje Andersen,Susana Aznar,Tomasz Brudek,Konstantin Khodosevich,Marco Prinz,Jean-François Marie Perrier,Manu Sharma,Thomas Gasser,Shohreh Issazadeh-Navikas

Journal of molecular biology 432:166689 PubMed33211011

2020

Megadalton-sized Dityrosine Aggregates of α-Synuclein Retain High Degrees of Structural Disorder and Internal Dynamics.

Applications

Unspecified application

Species

Unspecified reactive species

Silvia Verzini,Maliha Shah,Francois-Xavier Theillet,Adam Belsom,Jan Bieschke,Erich E Wanker,Juri Rappsilber,Andres Binolfi,Philipp Selenko

Cells 9: PubMed33066427

2020

Cytotoxicity and Mitochondrial Dysregulation Caused by α-Synuclein in .

Applications

Unspecified application

Species

Unspecified reactive species

Sanjanie Fernando,Claire Y Allan,Katelyn Mroczek,Xavier Pearce,Oana Sanislav,Paul R Fisher,Sarah J Annesley

eLife 9: PubMed32697196

2020

α-synuclein strains that cause distinct pathologies differentially inhibit proteasome.

Applications

Unspecified application

Species

Unspecified reactive species

Genjiro Suzuki,Sei Imura,Masato Hosokawa,Ryu Katsumata,Takashi Nonaka,Shin-Ichi Hisanaga,Yasushi Saeki,Masato Hasegawa

Antioxidants & redox signaling 32:636-655 PubMed31903784

2020

Regulation of the 20S Proteasome by a Novel Family of Inhibitory Proteins.

Applications

Unspecified application

Species

Unspecified reactive species

Maya A Olshina,Galina Arkind,Fanindra Kumar Deshmukh,Irit Fainer,Mark Taranavsky,Daniel Hayat,Shifra Ben-Dor,Gili Ben-Nissan,Michal Sharon
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com